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Apoptosis is a tightly controlled process regulated by many signaling pathways; however, the mechanisms and cellular events
that decide whether a cell lives or dies remain poorly understood. Here we showed that when a cell is under apoptotic stress, the
prosurvival protein Survivinredistributesfrom the cytoplasmto the nucleus,thus acting asa physiological switch to committhe
cell to apoptosis. The nuclear relocalization of Survivin is a result of inefﬁcient assembly of functional RanGTP–CRM1–Survivin
export complex due to apoptotic RanGTP gradient collapse. Subsequently, Survivin undergoes ubiquitination, which not only
physically prevents its diffusion back to the cytoplasm but also facilitates its degradation. Together, this spatial and functional
regulation of Survivin abolishes its cytoprotective effect toward the apoptotic executors and thus commits a cell to apoptosis.
Our data indicate that the withdrawal of Survivin is a novel and active physiological regulatory mechanism that tilts the survival
balance and promotes the progression of apoptosis.
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The signiﬁcance of apoptosis is never undermined given its
central role in normal development and homeostasis of
multicellular organism. Apoptosis progression relies on the
interplay between prosurvival factors and proapoptotic
factors, which crucially decides whether a cell under stress
lives or dies. The family of evolutionary conserved prosurvival
proteins, inhibitor of apoptosis proteins (IAPs), is essential
in protecting cells from entering apoptosis by negative
regulation of downstream caspases.
1–5 Survivin (16.5kDa)
is the smallest member of the IAP family containing a single
baculovirus IAP repeat motif and it is frequently overexpres-
sed and/or deregulated in most neoplastic tissues.
6–10 This
makes Survivin a leading research candidate in the develop-
ment of prognostical tool and a prime target in cancer
therapy.
11,12
As a member of the IAP, Survivin exhibits antiapoptotic
characteristics. Elevated level of Survivin has been reported
to confer radiation resistance, whereas artiﬁcial knockdown
of Survivin sensitizes and renders cells more susceptible to
irradiation-induced cell death.
13,14 Survivin is able to inhibit
the apoptotic executors; for example, caspases, due to its
cytoplasmiclocalization.It isactively and rapidlyexportedinto
the cytoplasm, as Survivin contains a canonical nuclear
export signal (NES) domain. The exclusion of Survivin from
the nucleus is mediated by the classic nuclear export
mechanism involving the interaction between the transport
receptor chromosomal region maintenance-1 (CRM1) and
Ran-guanosine50-triphosphate(RanGTP).
15–17Onadifferent
note, forced entry of modiﬁed Survivin mutants into the
nucleus by different groups has been associated to ubiquiti-
nation-mediated proteolysis by 26S proteasome.
18–20
Theoretically, the presence of prosurvival factors in the
cell renders the cell resistant to apoptotic stimuli. Hence, it is
conceivable that modulatory mechanisms are in place to
negate the effect of the prosurvival proteins and to intensify
the activation of proapoptotic proteins for the progression
of apoptosis. However, the fate and functionalities of exis-
ting prosurvival factors and proteins are incompletely eluci-
dated during cell death. The study herein describes a novel
regulatory pathway serving as a physiological switch to
mediate the removal of prevailing prosurvival protein Survivin
during the onset of apoptosis by the impairment of nuclear
exportprocessesthatactivelycontributestowardtheeventual
demise of the cell.
Results
Prosurvival protein Survivin is degraded during the
initial stages of apoptosis. We believed that in dying cells,
the tilt in balance and the convergence of the proapoptotic
factors could be due to the removal and/or inactivation of
the prosurvival factors. Thus, we sought to characterize
prosurvival proteins that might be affected in apoptotic cells.
Survivin is a suitable candidate not only because it is highly
expressed in cancer cells but also as an IAP, it is also a vital
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5,15,21 Western blot revealed a marked
decrease of total endogenous Survivin level in a time-depen-
dent manner (Figure 1a and Supplementary Figure S1a) upon
the induction of apoptosis (Figure 1b and Supplementary
Figure S1b). It is possible that the decline of endogenous
Survivin could be due to the decrease of Survivin mRNA
transcripts, or the post-translational degradation of the
protein or both. To address the likelihood of Survivin being
regulated at the transcription level during apoptosis, we
performed semiquantitative reverse transcription-PCR. Using
glyceraldehyde-3-phoshate dehydrogenase (GAPDH) as an
internal control, the level of Survivin mRNA appeared to be
relatively stable and unaffected during apoptosis (Figure 1c).
Hence, this effectively rules out apoptotic downregulation of
Survivin mRNA transcription.
Survivin turnover has been shown to be modulated by the
ubiquitin–proteasome proteolytic pathway.
20 To investigate
whether Survivin is similarly subjected to ubiquitin-related
degradation upon apoptosis induction, we performed Survivin
stability assay as denoted by the schematics in Figure 1d.
MG132 is used to block the proteosomal activity and
cyclohexamide (CHX) inhibits the synthesis of new proteins.
We found that endogenous Survivin proteins are degraded at
a faster rate in dying cells as compared with control cells
following the resumption of proteasome activity (Figure 1e).
Moreover,graphicalrepresentation(Figure1f)clearlyshowed
theprominentdecreaseinthestabilityofendogenousSurvivin
during apoptosis.
Survivin redistributes into the nucleus of early apoptotic
cells due to the collapse of RanGTP gradient. As Survivin
undergoes ubiquitin-dependent proteolysis in the nucleus,
19
it is possible that Survivin relocation occurs during the
progression of apoptosis. To test out this idea, immuno-
ﬂuorescence staining was performed against Survivin and
mAb414, marker for nuclear pore protein complexes (NPCs).
Indeed, we found that endogenous Survivin redistributes
from the cytoplasm into the nucleus of apoptotic cells in
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Figure 1 Apoptotic degradation of prosurvival protein Survivin (a) Total cell lysates collected at the stated time points after VP16 treatment and immunoblotted with anti-
Survivin and anti-actin (loading control). (b) VP16 treatment-induced cell death as shown by immunoblots of cleaved Caspase-3, cleaved PARP and cleaved ICAD. (c) Total
RNAs isolated from HeLa cells treated with or without VP16 at the indicated time points. Semiquantitative reverse transcription-PCR analysis was then performed using
GAPDHasinternal control.(d) Schematicrepresentation of Survivinstabilityassay.(e) Experiments performedas shownby theschematicsin(d).EndogenousSurvivinlevel
wasprobedatindicatedtimepointsaftertheresumptionoftheproteosomeactivity.Actinasloadingcontrol.(f)Quantiﬁedgraphicaldatapresentedasmean±S.D.(errorbar)
of three independent experiments
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Cell Death and Diseasea time-dependent manner (Figure 2a and Supplementary
Figure S2a). The nuclear envelope appeared to be intact
throughout the course of experiment, thus indicating that its
function as a physical barrier is not compromised. NPC
has been reported to be the substrates of caspases only
during late apoptosis.
22,23 To demonstrate that the relocation
of Survivin is a widespread phenomenon, we quantitate
the relative percentage of populations of HeLa cells having
distinctive Survivin localization. Consistently, control HeLa
cells showed predominantly cytoplasmic (cytoplasmic4
nuclear) localization of Survivin,
4,24 whereas the induction
of apoptosis triggered a signiﬁcant increase (Student’s t-test,
Po0.001) in the population showing predominantly nuclear
(nuclear4cytoplasmic) localization of Survivin (Figure 2b
and Supplementary Figure S2b). This suggests that
endogenous Survivin redistributes into the nucleus during
the early stages of apoptosis.
The nucleocytoplasmic shuttling ability of Survivin is
coordinated by passive diffusion and also the presence of
an intrinsic NES motif that directs Survivin export into the
cytoplasm by CRM1.
15,16,18,21 Hence, normal circumstantial
diffusion of Survivin into the nucleus would not lead to its
degradation as it is actively and rapidly exported back into
the cytoplasm. Immunostaining of Survivin and mAb414
performed on Leptomycin B (LMB) (potent CRM1 inhibitor)
or VP16-treated HeLa cells showed analogous nuclear
localization of endogenous Survivin as compared with control
(Figure 2c), hinting a possible error along RanGTP–CRM1–
Survivin axis. Given the importance of the RanGTP gradient
in nucleocytoplasmic trafﬁcking, we hypothesized that the
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Figure 2 RanGTP gradient collapse induces Survivin redistribution into the nucleus during apoptosis. (a) Survivin and mAb414 staining after VP16 treatment at indicated
time points. Images acquired with auto-optimal exposure mode. (b) Quantiﬁcation of cells with distinctive Survivin localization across the nucleocytoplasmic compartments.
Results are presented as mean population percentage of HeLa cells having distinctive Survivin localization ±S.D. (error bar) of three independent experiments (n4300
cells). (c) Immunostaining of non-treated, and treated HeLa cells with LMB or VP16 against Survivin and mAb414. (d) FRET analysis of the nuclear RanGTP gradient by
Rango biosensor (fusion protein of CFP and YFP ﬂanking an importinb binding domain). Rango undergoes FRET in the presence of RanGTP. Representative images (left)
and quantiﬁed data (right) presented as mean±S.D. (error bar) of three independent experiments (n¼120). *Po0.001 (Student’s t-test). (e) Flag-Survivin was
overexpressed, immunoprecipitated with anti-Flag from cells incubatedwith or without VP16 for 24h. Bars, 10mm. (right) Quantiﬁed Crm1 intensities normalizedagainst Flag
was presented as relative fold change ±S.D. (error bar) of three independent experiments
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Cell Death and Diseasenuclear export pathway could similarly be affected when
the RanGTP gradient collapsed upon apoptosis induction.
Using the acceptor photobleaching method of ﬂuorescence
resonance energy transfer (FRET), the nuclear RanGTP level
was measured as the relative percentage of FRET efﬁciency.
We showed that apoptosis induction results in a signiﬁcant
reduction of nuclear RanGTP level in HeLa cells (Figure 2d
and Supplementary Figure S3).
To investigate the interaction between Survivin and CRM1
during apoptosis, Flag-tagged Survivin was overexpressed
and immunoprecipitated using anti-Flag. Our data revealed
that the interaction between CRM1 and Flag-Survivin was
substantially weaker in the presence of apoptotic stimuli
(Figure 2e). This indicates that the apoptotic accumulation of
nuclear Survivin is driven by nuclear export deregulation by
the RanGTP–CRM1 pathway.
Re-establishment of RanGTP gradient rescues Survivin
redistribution. We speculated the possibility that the export
of endogenous Survivin into the cytoplasm could resume if
the RanGTP gradient recovers. In our earlier report, we have
established the use of mammalian STE20-like protein kinase 1
(Mst1) siRNA to restore diminished nuclear RanGTP
level.
25 Hence, by using the same strategy, we sought to
ﬁnd out whether Survivin could be exported to the cytoplasm
in the presence of apoptotic stimuli after Mst1 knockdown.
Western blot was performed on mock-transfected cells
and cells transfected with Mst1 siRNA or control siRNA to
verify the depletion of MST1 protein level. Treatment of
Mst1 siRNA achieved B80% knockdown efﬁciency, but does
not affect Survivin and Ran (Figure 3a). Consistently, the
depletion of MST1 restores nuclear RanGTP in cells treated
with VP16 (Figure 3b). A clear indication of RanGTP gradient
collapse is the mislocalization of Ran from predominantly
nuclear to being dispersed across the nucleocytoplasmic
compartment. As shown in Supplementary Figure S4a and b,
Mst1 knockdown restores the nuclear localization of Ran in
cells induced to undergo apoptosis. Immunostaining was
then carried out on cells transfected with Mst1 siRNA or
control siRNA, in the absence and presence of VP16. HeLa
cells transfected with Mst1 siRNA demonstrated cytoplasmic
localization of Survivin in apoptotic cells (Figure 3c). This
evidently indicates that restoration of the RanGTP gradient
reinstates the export of Survivin into the cytoplasm of HeLa
cells undergoing apoptosis.
Ubiquitinated Survivin are retained in the nucleus
pending proteolysis when nuclear export fails during
early apoptosis. To verify that the export deregulated
Survivin was post-translationally degraded in the nucleus,
CHX was used to block protein synthesis. As shown in
Figure 4a, treatment of CHX in the absence or presence of
VP16 exhibited a steady decline in endogenous Survivin
level for both the nuclear and also the cytoplasmic fractions.
As the Survivin mRNA transcripts are relatively unaffected by
VP16 as previously shown (Figure 1b), this data indicated
that existing Survivin was actively being degraded when
the protein translation process was inhibited. Treatment of
proteosome inhibitor MG132 restored both the VP16-treated
or non-treated endogenous Survivin protein level over time,
particularly in the nuclear fractions (Figure 4b). Western
blot illustrated that while Survivin level is stabilized in the
cytoplasmic fraction, there is a marked increase of Survivin
level in the nuclear fraction over time. More importantly,
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Figure 3 Restoration of RanGTP gradient reinstates Survivin export. (a) Immunoblotting against Mst1, Survivin, Ran and Actin was performed on lysates collected from
mock,ControlsiRNAorMst1siRNA-transfected HeLacells.(b) RangoFRETanalysiswas performedonMst1siRNAor ControlsiRNA-transfectedHeLa cells,with orwithout
VP16 treatment. Quantiﬁed data presented as mean±S.D. (error bar) of three independent experiments (n¼120). **Po0.001 (Student’s t-test) (c) HeLa cells transfected
with Mst1 siRNA or Control siRNA before 24h incubation with VP16. The cells were ﬁxed and stained with anti-Survivin and mAb414. Bar, 10mm. Images acquired with
auto-optimal exposure mode
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Cell Death and Diseaseexposure to MG132 demonstrated a greater restoration of
nuclear Survivin in samples treated with VP16. This suggest
that apoptosis accelerates the depletion of prosurvival factor
Survivin in the nucleus.
The collapse in RanGTP gradient and hence the failed
active transport system during the progression of apoptosis
could not fully explain the redistribution of Survivin into the
nucleus. Even as the active transport processes ceases,
Survivin (16.5kDa) can readily diffuse across the nuclear
membraneuntilequilibriumisreachedbetweenthecytoplasm
and the nucleus. However, Survivin is predominantly com-
partmentalized within the nucleus during apoptosis (Figure 2a
and Supplementary Figure S2a). This indicates that Survivin
is being sequestered in the nucleus after the export system
shuts down.
Upon further inspection, the Survivin stability assay
suggested that ubiquitinated Survivin in the nucleus could
lead to possible increase in sizes due to multiple conjugations
of ubiquitin molecules. NPCs function as selectivity ﬁlters
that allow molecules o40kDa to traverse across the nuclear
envelope. We reasoned that after the nuclear transport
machinery fails during apoptosis, ubiquitinated Survivin
molecules in the nucleus are prevented from diffusing out
due to their increased effective molecular weight 440kDa.
Western blot showed that apoptotic samples co-immunopre-
cipitated greater abundance of ubiquitinated Survivin proteins
at various molecular weights above 40kDa (Figure 4c).
Thus,apoptoticrelocationofSurvivinintothenucleusresulted
in multiple ubiquitination of Survivin that increases its
molecular weight up to B100kDa, thereby preventing
diffusion across the NPC after nuclear export is impeded.
Survivin cannot prevent apoptosis when compartmen-
talized in the nucleus. During the early stages of
apoptosis, Survivin relocates from the cytoplasm into the
nucleus due the collapse of RanGTP gradient, whereas both
the ProCaspase-3 and activated cleaved Caspase-3 remains
in the cytoplasm (Figure 5a and b). We reasoned that the
apoptotic accumulation of Survivin in the nucleus prevents
it from interacting with its target proteins in the cytoplasm.
As such, the cytoprotectivity of Survivin is compromised even
before it is degraded. To study the impact of nuclear Survivin
accumulation on apoptosis, we performed the Caspase-3
activity assay using the cleavage of Caspase-3 substrate
(Ac-DEVD-AMC) as ﬂuorogenic reporter. Instead of using
total lysates to probe for Caspase-3 activity, the cytoplasmic
fractions were used in line with prevalence of Caspase-3
in the cytoplasm after apoptosis induction consistent with
various reports that demonstrated that Caspase-3 only
enters the nucleus during late apoptosis when the nuclear
envelope breaks down. As Survivin redistributes into the
nucleus during apoptosis, parallel experiments were set up
involving a portion of the nuclear fraction being added back
to the corresponding cytoplasmic fraction before Caspase-3
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Figure 4 Ubiquitinated Survivin is sequestered and degraded in the nucleus upon apoptosis induction. (a) Nuclearcytoplasmic fractions were collected from CHX-treated
cells at the indicated time points. The experiment was repeated on HeLa cells incubated with CHX and VP16 simultaneously. The samples were immunoblotted against
Survivin, tubulin and GCN5. (b) Experiment was repeated as in (a) with the exception that CHX is replaced by MG132. (c) Survivin-WT-Myc was overexpressed and
immunoprecipitated with anti-Myc antibody from HeLa cells incubated with or without VP16 for 24h. The immunoprecipitated materials were immunoblotted against Survivin
and ubiquitin
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Cell Death and Diseaseactivity readout was taken. As shown in Figure 5e, the
addition of Survivin-containing nuclear fractions back its
corresponding cytoplasmic fractions yielded signiﬁcantly
lower Caspase-3 activity. To verify that the Caspase-3
inhibitory effect was due to the presence of Survivin in the
nuclear fraction, the assay was performed on HeLa cells
transfected with Survivin siRNA. Treatment of Survivin
siRNA achieved B90% knockdown efﬁciency of the
Survivin protein level (Figure 5c and d). The assay
revealed that nuclear fractions depleted of Survivin had
little effect on VP16-induced Caspase-3 activity (Figure 5e).
In other words, the knockdown of Survivin abolishes the
suppresive effect of the supplemented nuclear fraction
on cytoplasmic Caspase-3 activity, thus certifying that the
conﬁnement of Survivin in the nucleus reduces its
cytoprotectivity. This data corroborated other reports that
had demonstrated a link between cell death and the nuclear
enforcement of Survivin by NES-mutation experiments or
the expression of nuclear localization signal–Survivin fusion
proteins.
19,21,26 In addition, transfection of HeLa cells with
GST-Survivin-green ﬂuorescent protein (GFP) showed that
the mutant Survivin is retained in the cytoplasm due to its
increased size from passing through the NPC and reduces
the percentage of apoptotic cells in the presence of apoptotic
stimuli (Supplementary Figure S5). In summary, the anti-
apoptotic activity of Survivin is abrogated when it is
compartmentalized in the nucleus during the progression of
apoptosis.
Discussion
Apoptosis is a process whereby cells have an active role
leading to their own demise (cell suicide). The survival
factors function by upregulating the expression and/or activity
of antiapoptotic regulatory molecules and maintain the
dormancy of apoptotic executors. Upsetting this balance will
trigger the cells to initiate the execution of apoptosis. Hence, it
is tempting to speculate on the role of the cell, particularly
pertaining to the fate of existing prosurvival factors and
the molecular events that leads to its subsequent cell death.
In this study, we have reported a novel regulatory pathway
mediating the active removal of prevailing prosurvival protein
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time points. The samples were immunoblotted against Survivin, tubulin and GCN5. (b) Procaspase-3 and cleaved Caspase-3 are predominantly cytoplasmic in VP16-treated
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(f) Hypothetical model depicting the role of nuclear export system in regulating the commitment of cells during the onset of apoptosis
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Cell Death and DiseaseSurvivin during the onset of apoptosis by the impairment of
nuclear export machinery.
Survivin is an important bifunctional protein integral as
a component of the chromosome passenger complex and
also participates in the negative regulation of apoptotic
events. We have discovered that the prosurvival protein
Survivin is actively being removed by the ubiquitin–protea-
some proteolytic pathway upon the exposure to apoptotic
stimuli.Moreover, Survivinredistributes from the cytoplasmto
the nucleus during the progression of apoptosis. mAb414
staining indicates the preservation of the nuclear envelope
integrity throughout the duration of the experiment, thus
implying that the function of the nuclear membrane as a
selective physical barrier is not compromised.
For a cell under genotoxic stress, it is conceivable that the
prosurvival factors will proceed and attempt to rescue the cell
from dying. Then again, the cell will probably never die if the
prosurvival factor continues to exist and function. Our data
demonstrated that the relocation of endogenous Survivin into
thenucleusofHeLacellsisawidespreadphenomenonduring
the initial phases of apoptosis. The progressive accumulation
of endogenous Survivin in the nucleus was found to be
associated to the breakdown of the RanGTP gradient upon
apoptosis induction. In addition, this apoptotic nuclear
relocalization of Survivin is a recurring phenomenon as
observed even in the H1299 cells (Supplementary Figure
S6). As a small protein, Survivin is able to shuttle between
nuclear and cytoplasmic compartments by passive diffusion
under normal circumstances. Nonetheless, the presence of
an active NES directs continuous export of Survivin into the
cytoplasm by the interaction with its export receptor CRM1.
Although most NES by themselves have low afﬁnity for
the binding of CRM1,
27 the involvement of RanGTP in
the formation of the trimeric export complex is necessary for
efﬁcient cargo export. Further investigations revealed the
redistribution of endogenous Survivin in the nucleus is a
consequence of deregulation along the RanGTP–CRM1 axis.
The interaction between Survivin and CRM1 was found to be
signiﬁcantly weaker during early apoptosis. This precisely ﬁts
the model of cooperative binding between CRM1, RanGTP
and the NES-cargo as the basis of the functional trimeric
export complex assembly.
28,29 The decreased nuclear
RanGTP level interferes the trimeric RanGTP–CRM1–
Survivin complex formation and thus leads to diminished
export. Conversely, the restoration of RanGTP gradient by
Mst1 knockdown reinstated the cytoplasmic localization of
endogenous Survivin in apoptotic cells. Hence, we resolved
themechanismbehindthefailednuclearexportsystemduring
the initial phases of apoptosis.
In addition, failure to actively and rapidly transport Survivin
back into the cytoplasm helps to justify its decreasing protein
level in the course of apoptosis. The presence of Survivin
in the nucleus promotes its clearance by the ubiquitin–
proteasome proteolytic pathway. This corroborates previous
ﬁndings, which collectively reported the reduced stability of
Survivin in the nucleus as a result of proteasomal degrada-
tion.
19,20 More importantly, this implies that the cessation of
nuclear export could be the regulatory mechanism for the
intentional removal of prosurvival factor Survivin for cells to
commit to apoptosis. The conjugation of ubiquitin to Survivin
also partially explains how Survivin is retained in the nucleus
evenafterthenuclearexportprocessesareimpeded.Thesmall
molecular weight of Survivin should theoretically permit passive
diffusion back into the cytoplasm even as the RanGTP gradient
collapsed. We showed that apoptotic relocation of Survivin into
the nucleus resulted in multiple ubiquitination of Survivin that
effectively increases its molecular weight up to B100kDa,
thereby prevents diffusion across the NPC.
Survivin has been demonstrated by numerous studies to
directly and/or indirectly (by X-linked Inhibitor of apoptosis
protein or hepatitis B virus X-interacting protein) interact
and thus regulate the activities of caspases.
1–4,30 During
interphase, under normal circumstances, Survivin localizes
predominantly in the cytoplasm. Therefore, it can interact and
inhibit caspases that might be activated when the cell is under
stress. However, this does not mean that caspase activity
is only conﬁned to the cytoplasm. Although the effector
Caspase-3 is found in apoptotic nuclei, this observation is
commonly made during the later stages of apoptosis, usually
after the integrity of the nuclear membrane is compromised.
In recent years, a ﬂurry of studies has associated the
nuclear Survivin to the sensitization of viable cells to apop-
totic stimuli.
9,19,21 Here, we demonstrated that endogenous
Survivin had limited cytoprotectivity in the nucleus as it was
prevented from reaching and interacting with its protein
targets (such as the caspases) in the cytoplasm during
apoptosis. As described in the results section (Figure 5e), the
addition of Survivin-containing nuclear fractions back its
corresponding cytoplasmic fractions yielded signiﬁcantly low-
er Caspase-3 activity. It appears that the antiapoptotic activity
of Survivin is abrogated when it is compartmentalized in the
nucleus during the progression of apoptosis.
In conclusion, we have shown here that the nuclear export
machinery is impaired. More importantly, our data indicate
an unprecedented nuclearcytoplasmic transport associated
mechanism to regulate the removal of existing prosurvival
factor for cell death to occur (Figure 5f). The abolished
cytoprotectivity of Survivin couple to its degradation in the
nucleus ensures active withdrawal of positive signals during
the early stages of apoptosis. This regulatory mechanism
servesasaphysiologicaldecisionswitch,inwhichthesurvival
balance is consequently tilted and the unrestricted, wide-
spread activation of proapoptotic effector molecules will
irreversibly contributes toward apoptosis.
Materials and Methods
Cell culture and transfection. HeLa cells were obtained from American
Type Culture Collection and grown in Dulbecco’s modiﬁed Eagle’s medium (Gibco,
Invitrogen, Carlsbad, CA, USA) containing 10% fetal bovine serum (Hylcone,
Themo Scientiﬁc, Logan, UT, USA) and 1% Penicillin/Streptomycin (Gibco,
Invitrogen) at 371C in a humidiﬁed incubator with 5% carbon dioxide. Transfections
of Rango or Flag-Survivin into HeLa cells were carried out using Lipofectamine
2000, according to manufacturer’s instructions (Invitrogen).
Immunoﬂuorescence microscopy. Cells seeded onto 22mm coverslips
wereﬁxedwith4%paraformaldehydeinphosphate-bufferedsaline(PBS)for10min
and permeabilized with 0.5% Triton X-100 (USB, Cleveland, OH, USA) in PBS
for 5min. After washing three times with PBS, cells were blocked in 4% BSA
(Sigma-Aldrich, St. Louis, MO, USA) for 1h at room temperature (RT) and then
incubated with primary antibody diluted in TBST (50mM Tris, pH7.6, 150mM NaCl,
0.1% Tween-20) plus 4% BSA. Following washes with TBST, the cells were
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dark. Cells were then mounted onto glass slides using ProLong gold antifade
reagent containing 40,6-Diamidino-2-phenylindole (Invitrogen). Images were
acquired and analyzed using an Axiovert 200M inverted microscope (Carl Zeiss,
Standort Gottingen, Vertrieb, Germany) and Axiovision 4.6 software. Unless
speciﬁed, all images are acquired with ﬁxed exposures.
Reagents. For VP16 treatment, 10mg/ml VP16 (Sigma-Aldrich) in dimethyl
sulfoxide (DMSO) stock was diluted in medium to a ﬁnal concentration of 20mg/ml.
MG132 and CHX (both from Sigma-Aldrich) were diluted with buffers to a ﬁnal
working concentration of 2mM and 20mg/ml, respectively.For LMB (Sigma-Aldrich)
treatment,thestocksolutionof5mg/mlin100%ethanolwasdilutedwithbufferstoa
ﬁnal working concentration of 5ng/ml.
Antibodies. The antibodies used were anti-Survivin rabbit polyclonal Ab (R&D
Systems, Minneapolis, MN, USA); anti-actin goat polyclonal Ab (Santa Cruz
Biotechnology, Santa Cruz, CA, USA); mAb414 mouse monoclonal Ab (Covance
Research Product, Princeton, NJ, USA); anti-Ran goat polyclonal Ab (Santa Cruz
Biotechnology); anti-Caspase3 rabbit polyclonal Ab (Cell Signaling Technology,
Beverly,MA,USA);anti-FLAGM2mousemonoclonalAb(Sigma-Aldrich);anti-GCN5
rabbit monoclonal Ab (Cell Signaling Technology); anti-Myc rabbit monoclonal Ab
(Cell Signaling); anti-cmyc mouse monoclonal Ab (Santa Cruz Biotechnology);
anti-Mst1 rabbit polyclonal Ab (Cell Signaling Technology); anti-Ran goat polyclonal
Ab (Santa Cruz Biotechnology); anti-CRM1 mouse monoclonal Ab (BD Biosciences,
San Jose, CA, USA); anti-a-tubulin mouse monoclonal (Sigma-Aldrich); anti-cleaved
DFF45 (Asp224) rabbit polyclonal (Cell Signaling Technology); anti-cleaved PARP
(Asp214)rabbitpolyclonal(CellSignalingTechnology);AlexFluor488goatanti-rabbit
IgG (Invitrogen); Alex Fluor 594 goat anti-rabbit IgG (Invitrogen); and Alex Fluor 488
goatanti-mouseIgG(Invitrogen);horseradishperoxidase-conjugatedanti-mouseIgG,
anti-rabbit IgG and anti-goat IgG (Invitrogen).
Molecularcloning. To create the mammalianexpressionplasmids, full-length
Survivin was ampliﬁed (forward primer 50-TAGGGCGGATCCAGATGGGTGCCCC
GACGTTGC-30 and reverse primer 50-TAGGGCGAATTCTCAATCCATGGCAGCC
AGCTG-30) using HeLa cDNA library as template and pfu polymerase (Invitrogen).
ThecDNAlibrarywasgeneratedbyreversetranscription-PCRfromHeLatotalRNA
extracts. Survivin amplicons were then subcloned into the pcDNA3-FLAG vector
using BamH1 and EcoR1 sites or subcloned into pEF6/myc-His C vector using
BamH1 and EcoRV restriction sites. GST-Survivin-GFP contruct was generated
by subcloning GST-Survivin into pEGFP-N3 vector using HindIII and EcoR1 sites.
Time-Lapse imaging. Cells were seeded onto 60mm dishes and transfected
with empty vector or GST-Survivin-GFP for 2 days. The transfected cells were
then treated with or without VP16 and placed on a heat-controlled stage of a Zeiss
Axiovert 200M microscope. The temperature was maintained at 371C and CO2
levels were maintained at 5% using a CTI 3700 controller (Carl Zeiss). Phase
contrast and ﬂuorescent images were recorded (AxioCam camera and Axiovision
4.6 software, Carl Zeiss) using a 20  objective.
FRET. Lab-Tek Chambered cover glasses (Nunc, Rochester, NY, USA) were
used to seed the cells. FRET was then performed on a Zeiss LSM 510 Meta
confocal microscope equipped with Incubator S (Pecon, Erbach, Germany). During
the experiment, the temperature and CO2 level was maintained at 371C and 5%,
respectively, by placing the seeded cells in Incubator S on the microscope stage.
Acceptor Photobleaching method was used for FRET analysis of Rango
biosensor.
31 Rango consists of a cyan ﬂuorescence protein (CFP) and a yellow
ﬂuorescence protein (YFP) domain ﬂanking an importin-b binding domain. In brief,
the biosensor will have FRET when RanGTP is present. Five consecutive images
wereobtainedat1%ofthelaserintensityinCFPandYFPchannelsbeforeandafter
YFP photobleaching by repeatedly scanning the designated area at 75% laser
intensity. The background CFP ﬂuctuations during FRET were determined from the
unbleached control cells present in the same ﬁeld. FRET efﬁciency was calculated
asEF%¼(I6 I5) 100/I6,whereI5andI6representtheCFPﬂuorescenceintensity
of the ﬁfth and sixth images immediately before and after YFP photobleaching.
At least 15 cells were analyzed for each experimental set. Results were presented
as mean percentage FRET efﬁciencies ±S.D.
Preparation of cell extracts, immunoblotting and immuno-
precipitation. For the collection of whole cell lysates, HeLa cells were
washed with PBS and lysed by M-PER (mammalian protein extraction reagent;
Thermo Scientiﬁc-Pierce, Rockford, IL, USA) containing 10% Complete EDTA-free
Protease Inhibitor Cocktail (Roche, Basel, Schweiz, Switzerland) and 0.1%
phosphatase cocktail inhibitors 1 and 2 (Sigma-Aldrich). Nuclear cytoplasmic
fractionswerepreparedusingNE-PER(nuclearandcytoplasmicextraction)(Thermo
Scientiﬁc) according to manufacturer’s protocol.  2 sample buffer (62.5mM
Tris-HCl,pH6.8,2%SDS,25%glycerol,5%2-mercaptoethanol,0.01%bromophenol
blue) was added towhole celllysates, nuclearlysatesand cytoplasmiclysatesbefore
boiling the mixture for 10min. Equal amounts of protein were resolved on
SDS–polyacrylamide gel (PAGE) and transferred onto nitrocellulose membranes
(Bio-RadLaboratories,Hercules,CA,USA).Membraneswereblockedwith10%skim
milk in TBST for 2h at RT and probed with speciﬁc primary antibodies diluted in
blockingsolutionat41C overnight. MembraneswerewashedthricewithTBSTbefore
incubating with horseradish peroxidase-conjugated secondary IgG antibodies
(Invitrogen). After washing with TBST, immunoreactive proteins were detected by
enhanced chemiluminescence (GE Healthcare-BioSciences, Piscataway, NJ, USA).
For immunoprecipitation, HeLa cells stably transfected with Flag-Survivin or Survivin-
Wt-Myc and HA-Ub were incubated with or without VP16 for 24h. These cells were
then lysed with M-PER and the cell lysates wereincubated with the relevant antibody
for1hatroomtemperature.Rec-Protein-G-Sepharose4B(Invitrogen)wereaddedto
each experimental set. The resultant mixtures were further incubated for 1h at room
temperature before repeated washing with Wash buffer (TBS with 100mM NaCl) to
rid unbound proteins. Immunoprecipitated proteins were separated by SDS–PAGE
before western blotting analyses.
RNAi-mediated silencing of Mst1 and Survivin. Stealth select RNAi
for Mst1andSurvivin (bothfromInvitrogen)were usedto depleteMst1and Survivin
protein level, respectively, in HeLa cells. Mst1 silencing was carried out using
10nM of the oligo (AAUGAUAUCAGAUACAGAACCAGCC). Survivin depletion
on the other hand was performed using 10nM of the oligo (HSS141245). RNAi
negative control duplexes (Invitrogen) served as negative control in each experi-
mental set. The indicated RNAi were introduced into the cells by transfection using
Lipofectamine RNAiMAX (Invitrogen). The transfected cells were then harvested
24h later and resuspended in  2 SDS sample buffer and boiled. Depletion was
assessed by immunoblotting with the relevant antibodies.
Semiquantitative reverse transcription-PCR. Total RNA was
extracted from HeLa cells using the RNeasy kit (QIAGEN Inc., Valencia, CA,
USA) according to the manufacturer protocol. Total RNA from non-treated and
treated samples according to the time indicated were used for the preparation of
ﬁrst-strand cDNA by reverse transcription using the MMLV-based reverse
transcriptase (Stratagene, La Jolla, CA, USA). Human Survivin mRNA was
ampliﬁed using the forward primer 50-TAGGGCGAATTCATGGGTGCCCCGGAC
GTTGC-30 and the reverse primer 50-TAGGGCGGATCCTCAATCCATGGCAGC
CAGCTG-30 (corresponding to full-length Survivin sequence). GAPDH was also
ampliﬁedasaninternalcontrol.ThePCRcyclingconditionsweresetto25roundsto
prevent ampliﬁcation beyond the exponential phase. Reaction products were
analyzed on 1.0% agarose gels containing ethidium bromide.
Survivin stability assay. MG132 (Sigma-Aldrich) was used to accumulate a
pool of endogenous Survivin proteins from HeLa cells treated with or without VP16.
The cells were then washed three times with PBS to lift the proteasome inhibitory
effects of MG132. After MG132 washoff, the productions of new Survivin proteins
were terminated by the addition of CHX (Sigma-Aldrich). SDS–PAGE and western
blot were performed against Survivin for analysis and quantiﬁcation at each
indicated time points after MG132 release.
Caspase-3 activity assay and analyses. Nuclearcytoplasmic fractions
were prepared as described above from HeLa cells transfected Control RNAi,
Survivin RNAi or mock transfected, with or without VP16 treatment. Lysates were
snap-frozen and stored at  801C. Ninety-six-well microtiter plates (Nunc) were
used for this assay together with the caspase-3 substrate, ﬂuorogenic tetrapeptide
Ac-DEVD-AMC(Sigma-Aldrich).Aquantityof5ngofthesubstratewasincubatedat
371C for 3h in 200ml of reaction buffer (20mM HEPES, pH 7.4, with 2mM EDTA,
0.1% CHAPS and 5mM DTT) and 10ml of cytoplasmic extracts with or without 5ml
of the corresponding nuclear extracts. Spectroﬂuorometer measured ﬂuorescence
produced by substrate cleavage with excitation and emission wavelength set at
355 and 460nm, respectively. For each experimental set-up, results were
expressed as the mean relative percentage of caspase-3 activity between samples
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Cell Death and Diseasecontaining only the cytoplasmic extracts and samples containing both cytoplasmic
and nuclear extracts. For better and more accurate comparison, the read-outs
obtained from cytoplasmic extract only samples were set as the absolute value
(100%), such that the read-outs from the corresponding samples containing both
the cytoplasmic and nuclear extracts can be normalized accordingly.
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